Print

Purpose

This study evaluates the amount of nicotine, cannabis, and toxicants linked to the use of nicotine e-cigarette and/or cannabis products in the blood and urine of young adult users as well as the cannabis and nicotine use behaviors of consumers.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 25 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Young adult (18-25 years old). - Ability to read and write in English. - Participants must fall into one of the following groups (based on self-report): - Predominant e-cigarette consumer: defined as using nicotine-containing e-cigarettes daily for the past six months but not having used other nicotine containing products more than weekly or cannabis products for the past month. - Predominant cannabis consumer: defined as using cannabis at least 3x/week for the past six months in any form, including smoking, vaping, and oral use, with no more than weekly use of any nicotine or tobacco products. - E-cigarette-cannabis co-consumers: defined as daily use of nicotine e-cigarettes and use of cannabis at least 3x/week, including smoking, vaping, and oral use, for at least the past six months, with no use of other nicotine containing products more than weekly. - No self-reported diagnosis of kidney disease (current, or within the past year prior to the study visit). - Participants must understand the voluntary nature of this study and sign a written informed consent form before proceeding with study activities.

Exclusion Criteria

  • Individuals under the age of 18 or over the age of 25. - Currently pregnant or breastfeeding (female participants). - Unwilling or unable to follow protocol requirements

Study Design

Phase
Study Type
Observational
Observational Model
Case-Control
Time Perspective
Cross-Sectional

Arm Groups

ArmDescriptionAssigned Intervention
E-cigarette consumers Predominant e-cigarette consumers
  • Other: Effectiveness of different recruitment approaches
    Subjects will asked which type of recruitment material they've seen when completing the screening survey
  • Other: Choice of study completion locations
    subjects will choose location when coordinator calls to schedule appointment
  • Other: E-cigarette dependence Scale
    A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.
Cannabis consumers Predominant cannabis consumers
  • Other: Effectiveness of different recruitment approaches
    Subjects will asked which type of recruitment material they've seen when completing the screening survey
  • Other: Choice of study completion locations
    subjects will choose location when coordinator calls to schedule appointment
  • Other: Cannabis Engagement Assessment
    Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.
e-cigarette -cannabis coconsumers Consumers who use both e-cigarettes and cannabis .
  • Other: Effectiveness of different recruitment approaches
    Subjects will asked which type of recruitment material they've seen when completing the screening survey
  • Other: Choice of study completion locations
    subjects will choose location when coordinator calls to schedule appointment
  • Other: Cannabis Engagement Assessment
    Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.
  • Other: E-cigarette dependence Scale
    A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.

Recruiting Locations

Roswell Park Comprehensive Cancer Center
Buffalo, New York 14263
Contact:
ASK RPCI
877-275-7724

More Details

Status
Recruiting
Sponsor
Roswell Park Cancer Institute

Study Contact

ASK RPCI
1-800-767-9355
askroswell@roswellpark.org

Detailed Description

PRIMARY OBJECTIVE: I. To evaluate differences in self-reported nicotine and cannabis use behaviors and biomarkers of exposure to toxicants and carcinogens by product use status, to generate effect sizes required to calculate sample sizes needed for a larger study.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.